Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2006; 12(21): 3386-3392
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3386
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3386
Table 1 Patient characteristics
| Ulcerative colitis | Crohn's disease | |
| (n = 22) | (n = 24) | |
| Sex (M/F) | 13/9 | 14/10 |
| Age (yr) (mean and range) | 41 (18 – 78) | 42 (20 – 69) |
| Duration (yr) (mean and range) | 7.4 (0 – 30) | 9 (0 – 28) |
| Smoking habits (n) | ||
| Active | 2 | 3 |
| Former | 6 | 8 |
| Non-smoker | 7 | 9 |
| Unknown | 7 | 4 |
| Concomitant medication (n) | ||
| Aminosalicylates | 18 | 12 |
| Local steroids | 6 | 2 |
| Site of disease | ||
| Ileocolonic | 24 | |
| Rectum | 3 | |
| Proctosigmoiditis | 6 | |
| Extensive/total | 13 | |
| Disease activity index | ||
| (mean and range) | 9.4 (5 – 12) | |
| Harvey-Bradshaw index | ||
| (mean and range) | 14.9 (4 – 29) | |
| Endoscopic score | ||
| (mean and range) | 2.2 (1-3) | 2.1 (0-3) |
-
Citation: Ljung T, Lundberg S, Varsanyi M, Johansson C, Schmidt PT, Herulf M, Lundberg JO, Hellström PM. Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: Responders
versus nonresponders. World J Gastroenterol 2006; 12(21): 3386-3392 - URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3386.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i21.3386